Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 1,790 shares at $11.13 ($20K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Scheduled sale ($20k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TBPH | SELL | 2026-03-18 | $650K | — | Filing → |
| TBPH | SELL | 2025-12-05 | $1.2M | — | Filing → |
| TBPH | SELL | 2025-07-16 | $174K | — | Filing → |